Lv1
40 积分 2026-05-09 加入
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
15小时前
已完结
Platelets as drivers of immunothrombosis in rheumatic diseases
20小时前
已完结
Thrombosis as an intravascular effector of innate immunity
20小时前
已完结
Inhibiting thromboinflammation via interleukin-4 binding to platelet glycoprotein VI and suppression of thrombosis
2个月前
已关闭
Inhibiting thromboinflammation via interleukin-4 binding to platelet glycoprotein VI and suppression of thrombosis
2个月前
已完结
皖公网安备34019202002308
